DCF — DALLAS REGIONAL MEDICAL CENTER
Enterprise Value: $2.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$2.7M
Enterprise Value
$-2.0M
PV of Cash Flows
$4.7M
PV of Terminal Value
$7.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $109.8M | $2.9M | 3.0% | $-1.8M | $-1.6M |
| Year 2 | $113.1M | $4.1M | 4.0% | $-1.0M | $-0.8M |
| Year 3 | $116.4M | $5.4M | 5.0% | $-0.1M | $-0.1M |
| Year 4 | $119.9M | $6.2M | 5.0% | $0.3M | $0.2M |
| Year 5 | $123.5M | $6.7M | 5.0% | $0.6M | $0.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $2.7M. Terminal value accounts for 173% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$106.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.021550652450937152
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5